Attention Pharmacists and Pharmacy Techs: Click to access CPE Monitor and latest CE information More Information
This activity will cover key topics of interest to stakeholders who set practice policy and will be called upon to evaluate and make decisions on issues pertaining to biosimilars.
Choose from the criteria below to find an activity that fits you best.
Wednesday, December 13, 2017, 2:00-3:00pm ET / 11:00am-12:00pm PT
Register for Live Webinar
NOTE: If you are a member of SIDP or ACCP ID PRN, you can enter the code to participate in this activity at no cost.
Join us for this annual webcast that provides updates on hot topics related to antibiotic stewardship and microbiological testing. This year’s webcast will include the recurring CLSI antimicrobial susceptibility testing update but will also spotlight Clostridium difficile, one of the most problematic organisms in healthcare today. An overview of the current testing methods for C difficile will be provided and the relationship between antibiotic stewardship and C difficile reduction will be discussed.
Jennifer Dien Bard, Ph.D., D(ABMM), FCCM
Director, Clinical Microbiology and Virology Laboratory
Department of Pathology and Laboratory Medicine,
Children’s Hospital Los Angeles
Associate Professor, Clinical Pathology
Keck School of Medicine, University of Southern California
Dhara Surati, Pharm.D., BCPS
Clinical Assistant Professor
University of Houston College of Pharmacy
Department of Pharmacy Practice and Translational Research
This CE activity is jointly provided by ProCE, Inc., CLSI, and SIDP. ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-17-370-L01-P has been assigned to this knowledge-based live CE activity (initial release date 10-19-17). This CE activity is approved for 1.0 contact hour (0.1 CEU) in states that recognize ACPE providers. Successful completion of an online post-test and evaluation at www.ProCE.com is required to receive CE credit. No partial credit will be given.
Clinical and Laboratory Standards Institute is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.â Program. To receive Laboratory PACE credit, please email CLSI Marketing Contact, Shannon Sullivan at email@example.com and request PACE credit for this activity.
It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and
scientific rigor in all of its continuing education activities. Faculty must disclose
to participants any significant financial interest or affiliation with companies that
manufacture or market products discussed in this activity. Faculty disclosures will
be announced at the beginning of the CE activity.
Please note: The information and views presented in this activity are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this activity may include the use of drugs and/or devices for unlabeled indications, which should be considered experimental. Participants are advised to consult manufacturer product information and the professional literature, and use professional judgment in applying the presented information in patient-care activities.
This activity is self-funded by SIDP, CLSI, and members of ACCP ID PRN.
-Computer with broadband Internet access
-Soundcard and speakers or headphones for your computer (or dial-in via telephone for audio)
Click here for detailed software requirements.
After registering you will receive a confirmation email containing information about joining the Webinar.
The material presented in this CE activity does not reflect the views of ProCE, Inc. or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.